Tiago Marques insider trades

Open-market stock purchases and sales by Tiago Marques, Chief Executive Officer at Pasithea Therapeutics Corp, from SEC Form 4 filings since Dec 20, 2021.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -41%.

Recent trades

DateStockTradeValue
May 1, 2026KTTA Pasithea Therapeutics CorpBought (not open market)—
Nov 28, 2025KTTA Pasithea Therapeutics CorpBought$25K
Oct 24, 2025KTTA Pasithea Therapeutics CorpBought (not open market)—

Companies traded

  • KTTA Pasithea Therapeutics Corp: 1 buy, 1 sale, last May 1, 2026

Get free alerts when Tiago Marques files a new trade →